Posted from Healthcare Industry Today: ... 7 days ago
Hepatitis : Hepatitis News
... antibody, is in clinical trials by Peregrine Pharmaceuticals of California to treat patients with hepatitis C. Previous research has shown that phosphatidylserine-flipping occurs in cells infected with influenza, the ... (original story)
Posted from Search for "hepatitis&... 7 days ago
Hepatitis : Hepatitis News
Published: Monday, November 24, 2008 at 12:01 a.m. Last Modified: Sunday, November 23, 2008 at 10:54 p.m. With Thanksgiving just around the corner, there are some special people who deserve our thanks - our ... (original story)
Posted from Healthcare Industry Today: ... 7 days ago
Hepatitis : Hepatitis News
... a more immutable target." Bavituximab is currently in clinical trials to treat patients with hepatitis C. The trials have shown that treatment is safe for patients, and researchers are ... (original story)
Posted from Search for "hepatitis&... 7 days ago
Hepatitis : Hepatitis News
Women in the top rungs of California's major corporations are a rare breed. According to a UC Davis survey, women comprised just 11 percent of directors and senior executives in the state's 400 largest public ... (original story)
Posted from MedWorm: Hepatitis C 7 days ago
Hepatitis : Hepatitis News
Expert Opinion on Investigational Drugs , Early Online, Vol. 0, No. 0. Twelve drugs related to therapy and/or prevention of infectious diseases were discontinued from development during 2007. All of these agents were aimed at viral infections, primarily hepatitis C virus (six agents) and HIV (f... (original story)
Posted from MedWorm: Hepatitis C 7 days ago
Hepatitis : Hepatitis News
Hepatitis C vaccine: supply and demand. Lancet Infect Dis. 2008 Dec;8(12):739-740 Authors: Inchauspé G, Honnet G, Bonnefoy JY, Nicosia A, Strickland GT PMID: 19022189 [PubMed - as supplied by publisher] (Source: The Lancet Infectious Diseases) (original story)
Posted from Healthcare Industry Today: ... 7 days ago
Hepatitis : Hepatitis News
... that revenue and profits declined in Q3 (see ). In the quarter, its flagship hepatitis A vaccine, Healive, sold 28% fewer doses; AnFlu, the flu vaccine, sold almost one-third ... (original story)
Posted from Healthcare Industry Today: ... 7 days ago
Hepatitis : Hepatitis News
... some of which are summarized below: Kills viruses that cause influenza, herpes, measles, hepatitis C, SARS, AIDS, and other illnesses. Kills bacteria that cause ulcers, throat infections, ... (original story)
Posted from Search for "hepatitis&... 7 days ago
Hepatitis : Hepatitis News
Boys getting the recommended 3 Hep B shots, while the vaccines still contained Thimerosal, were NINE TIMES more likely to have a developmental disability than unvaccinated boys. (original story)
Posted from Search for "hepatitis&... 7 days ago
Hepatitis : Hepatitis News
The Journal Pioneer Editor, Nov. 24 to Dec. 1 marks AIDS Awareness Week in Prince Edward Island and around the world. (original story)
Posted from MedWorm: Hepatitis C 7 days ago
Hepatitis : Hepatitis News
Setting up an enhanced surveillance of newly acquired hepatitis C infection in men who have sex with men: a pilot in London and South East region of England. Euro Surveill. 2008;13(47) Authors: Ruf M, Cohuet S, Maguire H, Brant L, Ramsay M, Lattimore S, Delpech V, Preliminary findings s... (original story)
Posted from MedWorm: Hepatitis C 7 days ago
Hepatitis : Hepatitis News
Regulation of hepatitis C virus by microRNA-122. Biochem Soc Trans. 2008 Dec 1;36(6):1220-1223 Authors: Jopling CL Most metazoan miRNAs (microRNAs) bind to sites in the 3'-UTRs (untranslated regions) of mRNA targets and negatively regulate protein synthesis. The liver-specific miR-122, h... (original story)
Posted from Healthcare Industry Today: ... 7 days ago
Hepatitis : Hepatitis News
... infections in animal disease models. Bavituximab is in clinical trials for the treatment of hepatitis C virus (HCV) infection and in preclinical development for the treatment of viral hemorrhagic ... (original story)
Posted from News on Hepatitis from BioP... 7 days ago
Hepatitis : Hepatitis News
Revolution Health: (original story)
Posted from Healthcare Industry Today: ... 7 days ago
Hepatitis : Hepatitis News
... a more immutable target. Bavituximab is currently in clinical trials to treat patients with hepatitis C. The trials have shown that treatment is safe for patients, and researchers are ... (original story)